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The aim of this work is the creation of a technological basis for the development and production
of biologically active substances (BAS), namely, vitamins and hormones, valuable for medicine, agriculture,
chemical, food and microbiological industry. This goal can be achieved by studying of the physico-chemical
properties and structural-functional relationships of biological objects by methods such as, vacuum adiabatic
calorimetry, combustion calorimetry, x-ray diffraction and other. For the production of synthetic drugs
it is necessary to study their properties, which can be used to create and improve existing methods
for the production and purification of substances by means of the computer programs. Such programs
allow to realize the computer synthesis based on the data on the structure of the compounds, the thermo-
dynamic parameters of substances and the chemical reactions is selected as the main criteria for programming.
Study of structural properties and polymorphism has great importance for industry because the polymorphic
forms of a drug differ in physico-chemical properties, such as solubility, chemical and physical stability,
hygroscopicity, tableting, and biological activity. At the moment we investigated the structural and thermo-
dynamic properties of B vitamins and steroid hormones (Table 1, 2).
Riboflavin
Nicotinic acid
Myo-inositol
Folic acid dihydrate
L-carnitine
Cyanocobalamin
Methylprednisolone
Methylprednisolone aceponate
Prednisolone
Hydrocortisone acetate
T a b l e  1
Thermodynamic characteristics of formation of biologically active substances
1961 ±3
503 ±3
1232,5 ±3,5
2515,5 ±9,5
1182,5 ±3,5
7281 ±5
2141 ±11
2592,9 ±13,7
–
–
1432 ±13
344,9 ±0,9
1329,3 ±2,3
1821,0 ±5,7
756,2 ±2,5
5017 ±15
1045,8 ±7,3
1465,3 ±9,8
1020,6 ±7,6
1307,0 ±11,6
Compound –
f 
H°(298) (kJ/mol) –
f 
S°(298) (J/(mol·K)) –
f 
G°(298) (kJ/mol)
847 ±14
195 ±2
962 ±3
1071 ±6
403,5 ±3
2846 ±15
407 ±8
692 ±10
–
–
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Sample
Symmetry, Z
a, Å 
b, Å 
c, Å 
, °
V, Å3
T a b l e   2
Crystallographic parameters of biologically active substances
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Propanol solvates
cortisone acetate
Monoclinic P2
1
, 2
9,8941 (3)
7,3833 (2)
16,5816 (5)
90,110
1211,30 (6)
Orthorhombic
P2
1
2
1
2
1
, 4
6,57348 (14)
14,8295 (3)
26,2214 (5)
–
2556,11 (9)
Methylprednisolone aceponate
Orthorhombic
P2
1
2
1
2
1
, 12
14,8592 (2)
19,6844 (5)
26,2214 (5)
–
7652,4 (2)
Ethanol solvates
cortisone acetate
Monoclinic P2
1
, 2
9,6973 (4)
7,4950 (3)
16,1828 (7)
93,559
1173,92 (8)
